Скачать или смотреть Blinding of Bioequivalence Trials (9of11) GCP Data Integrity

CDER’s Director of the Division of Generic Drug Bioequivalence Evaluation Seongeun (Julia) Cho discusses bioequivalence studies, blinding codes, FDA inspections, and case examples.

For more data integrity case studies, visit https://www.fda.gov/drugs/cder-small-...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia

CDER SBIA 2018 Playlist:    • 2018 CDER Small Business and Industry Assi...  
LinkedIn:   / cder-small-business-and-industry-assistance  
Training resources: https://www.fda.gov/cderbsbialearn

Twitter:   / fda_drug_info  

CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367